Get started
Author

Geneviève Loos

Observed names: G. Loos, Genevieve Loos, LOOS, Geneviève
Institution: Centre Jean Perrin
ORCID: 0000-0002-1554-0646
Observed ORCID: 0000-0002-1554-0646
OpenAlex ID: A5049756209
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer
2021 · Stéphane Supiot, Loig Vaugier, et al. · European Urology · 96
PDF
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)
2018 · Loig Vaugier, Clément Palpacuer, et al. · International Journal of Radiation Oncology*Biology*Physics · 43
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
2023 · David Pasquier, Thomas Lacornerie, et al. · European Urology Oncology · 41
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07)
2024 · Loig Vaugier, Cyrille Morvan, et al. · European Urology · 26
Delineation of the Prostate Bed: The “Invisible Target” Is Still an Issue?
2017 · Igor Latorzeff, Paul Sargos, et al. · Frontiers in Oncology · 22
PDF
Délinéation des cancers de la cavité buccale et de l’oropharynx
2013 · M. Lapeyre, G. Loos, et al. · Cancer/Radiothérapie · 19
Délégation partielle du contrôle de position du patient par imagerie embarquée aux manipulateurs en électroradiologie
2013 · G. Loos, J. Biau, et al. · Cancer/Radiothérapie · 12
Irradiation panencéphalique des métastases cérébrales : la technique d’irradiation influence la dose aux glandes parotides
2012 · G. Loos, R. Paulon, et al. · Cancer/Radiothérapie · 10
Oligopelvis-GETUG P07: A multicenter phase II trial of combined salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses of prostate cancer.
2020 · Stephane Supiot, David Pasquier, et al. · Journal of Clinical Oncology · 7
Radiothérapie guidée par l’image et partage des tâches avec les manipulateurs en électroradiologie : expérience de Clermont-Ferrand
2013 · G. Loos, J. Moreau, et al. · Cancer/Radiothérapie · 7
Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer
2017 · Juliette Moreau, Julian Biau, et al. · Cureus · 4
PDF
Radiotherapy for penile cancers: 2025 update
2025 · Geneviève Loos, Alexandre Escande, et al. · Cancer/Radiothérapie · 3
Chimioradiothérapie concomitante des cancers du sein inflammatoire, non métastatiques, non répondeurs à une chimiothérapie première
2015 · A. Bellière-Calandry, C. Benoît, et al. · Cancer/Radiothérapie · 3
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial
2026 · Hugo Corda, Audrey Blanc-Lapierre, et al. · Radiotherapy and Oncology · 2
Role of radiotherapy in the management of bladder cancer: Recommendations of the Société française de radiothérapie oncologique, 2025 update
2025 · Paul Sargos, Louis-Marie Sauvage, et al. · Cancer/Radiothérapie · 2
Délégation partielle du contrôle quotidien de position de la prostate par tomographie conique aux manipulateurs en électroradiologie médicale
2017 · C. Benhaïm, G. Loos, et al. · Cancer/Radiothérapie · 2
Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study
2026 · Ewen Anger, Stephane Supiot, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
1578 Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS retrospective study
2025 · Ewen Anger, Stéphane Supiot, et al. · Radiotherapy and Oncology · 1
PSMA PET/CT patterns of recurrence after mono-brachytherapy in men with low and intermediate prostate cancer and subsequent management
2024 · Genevieve Loos, James Patrick Buteau, et al. · Brachytherapy · 1
PDF
Consolidative radiotherapy for metastatic urothelial bladder cancer patients without progression and with no more than three residual metastatic lesions following first line systemic therapy: A prospective randomized comparative phase II trial (BLAD RAD01/GETUG-AFU V07).
2021 · Jonathan Khalifa, Damien Pouessel, et al. · Journal of Clinical Oncology · 1
Délégation partielle aux manipulateurs en électroradiologie médicale du contrôle quotidien de position de la prostate par tomographie conique
2015 · C. Benhaim, G. Loos, et al. · Cancer/Radiothérapie · 1
Study Protocol of OLIGOPELVIS 2–GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer
2026 · Quentin Josset, Audrey Blanc-Lapierre, et al. · European Urology Oncology
2263 Early Toxicity of elective nodal RT for Oligorecurrent Pelvic/Paraaortic nodes in Prostate Cancer: a randomised phase 3 trial OLIGOPELVIS-2/GETUG P12.
2026 · Hugo Corda, Audrey Blanc-Lapierre, et al. · Radiotherapy and Oncology
Re: Riccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. 2026;9:408–416. https://doi.org/10.1016/j.euo.2026.01.005
2026 · Genevieve Loos, Paul Sargos, et al. · European Urology Oncology
Physical activity and exercise in cervical cancer: a state-of-the-art review
2026 · Genevieve Loos, Martine Duclos, et al. · Cancer Causes & Control
Works count: 39
Citation count: 304
H-index: 8
I10-index: 8
Year
Topic
Type